Pubblicazioni

Combination strategies involving immune checkpoint inhibitors and tyrosine kinase or BRAF inhibitors in aggressive thyroid cancer

2022 - INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Ragusa, Francesca; Martina Ferrari, Silvia; Elia, Giusy; Rosaria Paparo, Sabrina; Balestri, Eugenia; Botrini, Chiara; Patrizio, Armando; Mazzi, Valeria; Guglielmi, Giovanni; Foddis, Rudy; Spinelli, Claudio; Ulisse, Salvatore; Antonelli, Alessandro; Fallahi, Poupak

Personalized and targeted mutational analysis of multiple second primary melanomas under kinase inhibitors

2021 - ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY

Donati, Michele; Zelano, Giovanni; Coppola, Rosa; Cinelli, Eleonora; Verri, Martina; Persichetti, Paolo; Perrella, Eleonora; Devirgiliis, Valeria; Calvieri, Stefano; Crescenzi, Anna; Panasiti, Vincenzo

A new water soluble MAPK activator exerts antitumor activity in melanoma cells resistant to the BRAF inhibitor vemurafenib

2015 - BIOCHEMICAL PHARMACOLOGY

Graziani, Grazia; Artuso, Simona; De Luca, Anastasia; Muzi, Alessia; Rotili, Dante; Scimeca, Manuel; Atzori, Maria Grazia; Ceci, Claudia; Mai, Antonello; Leonetti, Carlo; Levati, Lauretta; Bonanno, Elena; Tentori, Lucio; Caccuri, Anna Maria